First Time Loading...

Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426

Watchlist Manager
Shandong Hualu-Hengsheng Chemical Co Ltd Logo
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
Watchlist
Price: 30.37 CNY -0.59%
Updated: May 14, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

44.1B
+7%
Assets
Growth Rates:
1 Year
+26%
3 Years
+114%
5 Years
+136%
7 Years
+234%
10 Years
+246%
15.2B
+18%
Liabilities
Growth Rates:
1 Year
+88%
3 Years
+198%
5 Years
+130%
7 Years
+201%
10 Years
+120%
28.9B
+2%
Equity
Growth Rates:
1 Year
+7%
3 Years
+87%
5 Years
+139%
7 Years
+254%
10 Years
+392%

Balance Sheet Decomposition
Shandong Hualu-Hengsheng Chemical Co Ltd

44.1B
Assets
15.2B
Liabilities
44.1B
Assets
15.2B
Liabilities
Current Assets 7.9B
Cash & Short-Term Investments 1.9B
Receivables 3.9B
Other Current Assets 2.2B
Non-Current Assets 36.1B
PP&E 32.2B
Intangibles 1.9B
Other Non-Current Assets 2B
Current Liabilities 5.8B
Accounts Payable 3.3B
Accrued Liabilities 394.4m
Short-Term Debt 694.6m
Other Current Liabilities 1.4B
Non-Current Liabilities 9.4B
Long-Term Debt 7.4B
Other Non-Current Liabilities 2B

Balance Sheet
Shandong Hualu-Hengsheng Chemical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
949
424
621
754
1 283
715
1 066
1 784
1 770
1 871
Cash
0
0
0
0
0
0
0
1 784
1 770
1 871
Cash Equivalents
949
424
621
754
1 283
715
1 066
0
0
0
Short-Term Investments
0
0
0
0
1 080
1 293
1 004
1 005
1 406
0
Total Receivables
1 276
653
705
962
1 225
1 021
721
3 868
3 339
3 896
Accounts Receivables
32
30
17
41
23
34
23
76
39
57
Other Receivables
1 244
623
688
921
1 202
987
698
3 792
3 300
3 839
Inventory
337
246
519
402
557
332
273
1 039
1 173
1 493
Other Current Assets
139
150
152
130
171
130
202
695
893
662
Total Current Assets
2 702
1 472
1 998
2 247
4 317
3 491
3 267
8 391
8 581
7 923
PP&E Net
9 675
9 677
10 570
13 157
13 543
13 539
15 984
17 330
20 648
32 161
PP&E Gross
9 675
9 677
10 570
13 157
13 543
13 539
15 984
17 330
20 648
32 161
Accumulated Depreciation
4 236
4 810
5 719
6 649
7 590
8 812
10 008
11 099
12 836
14 686
Intangible Assets
345
337
523
518
696
1 070
1 238
1 497
1 737
1 947
Other Long-Term Assets
328
123
115
100
102
88
60
1 435
4 039
2 021
Total Assets
13 050
N/A
11 609
-11%
13 206
+14%
16 022
+21%
18 657
+16%
18 187
-3%
20 549
+13%
28 653
+39%
35 005
+22%
44 051
+26%
Liabilities
Accounts Payable
793
679
726
1 330
1 568
824
1 458
2 192
1 624
3 314
Accrued Liabilities
43
56
77
88
151
166
263
319
343
394
Short-Term Debt
188
30
740
660
270
0
530
10
0
695
Current Portion of Long-Term Debt
1 089
1 343
1 117
1 060
1 338
914
718
660
473
282
Other Current Liabilities
314
274
293
462
651
530
744
1 038
1 130
1 103
Total Current Liabilities
2 427
2 381
2 953
3 601
3 978
2 434
3 714
4 219
3 571
5 788
Long-Term Debt
3 844
1 792
2 065
3 115
2 594
1 504
1 175
1 715
3 272
7 361
Deferred Income Tax
0
0
0
0
0
2
1
4
15
12
Minority Interest
0
0
0
0
0
0
180
450
998
1 547
Other Liabilities
166
60
26
17
17
16
11
10
227
453
Total Liabilities
6 437
N/A
4 234
-34%
5 044
+19%
6 733
+33%
6 589
-2%
3 956
-40%
5 081
+28%
6 397
+26%
8 082
+26%
15 160
+88%
Equity
Common Stock
954
959
1 247
1 620
1 627
1 627
1 627
2 112
2 123
2 123
Retained Earnings
3 331
4 093
4 585
5 682
8 459
10 586
11 817
18 096
22 704
24 587
Additional Paid In Capital
2 328
2 362
2 369
2 012
2 063
2 073
2 080
2 066
2 318
2 386
Treasury Stock
0
39
39
26
80
55
55
18
222
204
Total Equity
6 613
N/A
7 375
+12%
8 161
+11%
9 289
+14%
12 068
+30%
14 231
+18%
15 469
+9%
22 256
+44%
26 923
+21%
28 891
+7%
Total Liabilities & Equity
13 050
N/A
11 609
-11%
13 206
+14%
16 022
+21%
18 657
+16%
18 187
-3%
20 549
+13%
28 653
+39%
35 005
+22%
44 051
+26%
Shares Outstanding
Common Shares Outstanding
2 095
2 084
2 095
2 095
2 095
2 099
2 099
2 097
2 097
2 097

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.